# Sliding hydrogels for accelerating cartilage regeneration

> **NIH NIH R01** · STANFORD UNIVERSITY · 2021 · $435,432

## Abstract

Articular cartilage injury represents one of the leading causes of disability. Current treatments for repairing
cartilage defects rely mostly on surgical intervention to restore articular surface, yet often result in undesirable
fibrocartilage formation with poor long-term outcomes. While both synthetic and natural hydrogels have shown
efficacy in supporting MSC chondrogenesis in 3D, conventional hydrogels generally lead to slow neocartilage
deposition by MSCs in 3D restricted to peri-cellular regions, resulting in long delay before significant increase
in mechanical strength. Given articular cartilage is a weight-bearing tissue, there remains a critical need for
novel scaffolds to accelerate cartilage deposition by MSCs in 3D with improved mechanical strength.
During cartilage development, cell-matrix and cell-cell adhesions play an important role in the mesenchymal
condensation process, which involves multiple ligand types and cell-mediated ligand clustering. However,
conventional covalently crosslinked hydrogels are characterized by fixed crosslinks and ligands, which do not
allow cells to re-organize the surrounding niche cues. To address the above limitations, our group has recently
reported sliding hydrogels with mobile crosslinks and biochemical ligands as a 3D niche. The molecular
mobility of the sliding hydrogels enables the cells to reorganize ligands and cytoskeleton in 3D, and
substantially accelerates cartilage matrix production with improved mechanical strength than conventional non-
mobile hydrogels. We hypothesize that: (1) increasing molecular mobility will accelerate chondrogenesis and
neocartilage deposition by human MSCs in 3D; and (2) varying the type and density of ligands will further
enhance cartilage formation by MSCs with improved mechanical strength in vitro and in vivo. By fusing
principles and tools from material science, stem cell biology, animal models and imaging, we have assembled
a multidisciplinary team of basic and clinician scientists to test the above hypotheses by pursuing the following
aims: Aim 1: Develop and characterize sliding hydrogels with tunable molecular mobility and biochemical
ligands as a 3D stem-cell niche. Aim 2. Examine the impact of varying molecular mobility on modulating the
speed and quality of neocartilage formation by MSCs in 3D sliding hydrogels. Aim 3. Evaluate the effect of
varying the types and density of mobile biochemical ligands on MSC-based cartilage tissue formation, and
explore potential molecular mechanisms by which molecular mobility modulate stem cell fates in 3D. Aim 4:
Assess the role of the molecular mobility of sliding hydrogels in accelerating MSC-based cartilage formation in
vivo using a rat osteochondral defect model. Upon completion of the project, we expect to identify sliding
hydrogels with optimized molecular mobility and biochemical ligands as novel matrices to accelerate the speed
of cartilage regeneration by MSCs with substantially improved mechanical strength...

## Key facts

- **NIH application ID:** 10244981
- **Project number:** 5R01AR074502-03
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Fan Yang
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $435,432
- **Award type:** 5
- **Project period:** 2019-09-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10244981

## Citation

> US National Institutes of Health, RePORTER application 10244981, Sliding hydrogels for accelerating cartilage regeneration (5R01AR074502-03). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10244981. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
